Aligos Therapeutics, Inc. (ALGS) Insider Trading

Name: Aligos Therapeutics, Inc. (ALGS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 29, 2026): Heather Preston (Director): Grant/Award of 5,860 shares.

Get alerted when insiders trade ALGS

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta